This inventor holds 1 USPTO granted patent. Top assignee: Yale University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Albert DeBerardinis: Innovator in RNA Inhibition
Introduction
Albert DeBerardinis is a notable inventor based in West Hartford, CT (US). He has made significant contributions to the field of molecular biology, particularly in the area of RNA inhibition. His work focuses on developing methods to address diseases associated with group II introns.
Latest Patents
DeBerardinis holds a patent for "Compositions and methods for inhibiting group II intron RNA." This invention provides compositions and methods aimed at inhibiting group II intron splicing, which can be crucial for treating or preventing diseases linked to organisms harboring active group II introns. The patent also outlines methods for reducing the growth of such organisms.
Career Highlights
Albert DeBerardinis is affiliated with Yale University, where he conducts his research and development. His work has garnered attention for its potential applications in medical science and biotechnology. He has been recognized for his innovative approaches to complex biological problems.
Collaborations
DeBerardinis has collaborated with esteemed colleagues, including Anna Marie Pyle and Olga Fedorova. These partnerships have contributed to the advancement of research in RNA biology and its implications for health.
Conclusion
Albert DeBerardinis stands out as an influential inventor in the realm of RNA inhibition, with a focus on innovative solutions for medical challenges. His contributions continue to shape the future of molecular biology and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile